IDEAYA Biosciences, Inc. - Common Stock (IDYA)

Historical Holders from Q2 2019 to Q3 2025

Symbol
IDYA on Nasdaq
CUSIP
45166A102
Type / Class
Equity / Common Stock
Shares outstanding
88.1M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
94.1M
Holdings value
$2.56B
% of all portfolios
0.003%
Grand Portfolio weight change
0%
Number of holders
219
Number of buys
124
Number of sells
-88
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of IDEAYA Biosciences, Inc. - Common Stock (IDYA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.1% -16% $136M -$23.8M 7.13M -14.9% BlackRock, Inc. Mar 31, 2025
Capital Research Global Investors 7.5% $138M 6.55M Capital Research Global Investors Jun 30, 2025
JANUS HENDERSON GROUP PLC 7.3% +5.71% $175M $6.04M 6.43M +3.58% JANUS HENDERSON GROUP PLC Sep 30, 2025
Point72 Asset Management, L.P. 5% $80.2M 4.41M Point72 Asset Management, L.P. Jun 6, 2025

Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 94.1M $2.56B -$71.2M $27.21 219
2025 Q2 96.8M $2.04B +$85M $21.02 200
2025 Q1 93.9M $1.54B +$4.22M $16.38 203
2024 Q4 91.9M $2.36B -$38.9M $25.70 203
2024 Q3 91.9M $2.91B +$266M $31.68 208
2024 Q2 82.5M $2.9B +$113M $35.11 196
2024 Q1 79M $3.47B +$577M $43.88 201
2023 Q4 64.7M $2.3B +$298M $35.58 153
2023 Q3 59.7M $1.61B +$91.5M $26.98 142
2023 Q2 56.6M $1.33B +$273M $23.50 138
2023 Q1 45.5M $625M -$7.49M $13.73 126
2022 Q4 46M $835M +$24.1M $18.17 116
2022 Q3 44.7M $667M +$139M $14.92 110
2022 Q2 35.4M $489M +$8.39M $13.80 95
2022 Q1 35M $391M -$45.8M $11.19 100
2021 Q4 34.7M $821M +$42.9M $23.64 109
2021 Q3 32.9M $838M +$191M $25.49 90
2021 Q2 25.4M $533M +$25.5M $20.99 83
2021 Q1 23.8M $605M +$111M $23.50 87
2020 Q4 20.3M $284M +$21.4M $14.00 81
2020 Q3 18.9M $237M +$3.53M $12.56 66
2020 Q2 18.5M $262M +$120M $14.21 64
2020 Q1 10.9M $45M -$1.2M $4.12 24
2019 Q4 11.2M $83.6M -$5.01M $7.50 27
2019 Q3 5.57M $49.5M -$828K $9.00 24
2019 Q2 5.65M $56.3M +$56.3M $9.96 24